ロード中...
RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis
PURPOSE: The mode of action of targeted cancer agents (TCAs) differs from classic chemotherapy, which leads to concerns about the role of RECIST in evaluating tumor response in trials with TCAs. We investigated the performance of RECIST using a pooled database from 50 clinical trials with at least o...
保存先:
| 出版年: | J Clin Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494357/ https://ncbi.nlm.nih.gov/pubmed/30860949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01100 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|